NCT05893927Recruiting
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 30 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study. Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study. Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled. Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- First submitted
- 30 May 2023
- Start date
- 15 Feb 2024
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- The Reading Hospital and Medical Center
- Diseases
- Type 2 diabetes
- NCT number
- NCT05893927
What you commit to
- Study type: Interventional
- Planned participants: 65
- From 15 Feb 2024 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Identified special populations (pregnancy or individuals currently incarcerated)
- Patients without access to their own smart phone
- Any patient who is unable to provide their own informed consent to participate in the study
Who the study is looking for
- Age ≥ 18 years
- Diagnosis of Type 2 Diabetes with HA1c \>8.0
- Current patients of the Family Healthcare Center, Reading Hospital Tower health.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Reading Hospital, an affiliate of Tower Health Coordinator of this site? Confirm its status | West Reading | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.